Back to search

Article

Determinants of hydroxychloroquine-mediated hemolytic anemia in G6PD-deficient COVID-19 patients

2022-05-19

Abstract excerpt

<h4>Aims: </h4> To identify the factors contributing to hydroxychloroquine (HCQS)-mediated hemolytic anemia in G6PD deficient COVID-19 patients. Materials and Methods We have developed Multiple linear regression (MLR) and classification and regression tree (CART) models based on the published data (n = 13) and evaluated the impact of G6PD variants in exerting hemolysis. Results African Ancestry subjects had sig...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a3c68cb4-b147-5c24-80a1-de15ed9c1fcc
DOI
10.21203/rs.3.rs-1672676/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Determinants of hydroxychloroquine-mediated hemolytic anemia in G6PD-deficient COVID-19 patientsDOI 10.21203/rs.3.rs-1672676/v1
Clinical Spectrum of Sickle Cell Disease and COVID-19: Laboratory and Clinical Factors Associated with Morbidity and MortalitySemantic proximity
Sickle Cell Disease Demographics and Clinical Epidemiology in Gambian Urban and Rural Cohorts Retrospective AnalysisSemantic proximity
Vitamin C induced hemolysis: Meta summary and review of literatureSemantic proximity
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.Semantic proximity
Exploring Pharmacogenetic Factors Influencing Hydroxyurea Response in Tanzanian Sickle Cell Disease Patients: A Genomic Medicine ApproachSemantic proximity
Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives.Semantic proximity
Exploring pharmacogenetic factors influencing hydroxyurea response in tanzanian sickle cell disease patients: a genomic medicine approach.Semantic proximity
A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemicSemantic proximity
G6PD deficiency: global distribution, genetic variants and primaquine therapy.Semantic proximity
Disentangling the association of hydroxychloroquine treatment with mortality in Covid-19 hospitalized patients through Hierarchical ClusteringSemantic proximity
The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.Semantic proximity
Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype.Semantic proximity
Select a neighboring publication to make it the new centre.